Join TScan Therapeutics for a virtual KOL event, featuring hematologist/oncologists Ran Reshef, MD, MSc (Columbia University Irving Comprehensive Cancer Center) and Monzr M. Al Malki,…
Access the replay for more information.
Join Reviva Pharmaceuticals for a virtual key opinion leader (KOL) event, featuring Larry Ereshefsky, PharmD, BCPP, FCCP (Retired professor of Psychiatry,…
Join FibroGen for Part I of a virtual KOL investor event series featuring Andrew Ko, MD (University of California San…
Join Abivax for a virtual KOL investor event featuring Marla Dubinsky, MD (Professor of Pediatrics and Medicine, Icahn School of Medicine Mount…

Join Oryzon Genomics for a virtual KOL Event to briefly review, then discuss the topline results from the Phase IIb…
Join Vera Therapeutics for a hybrid R&D day, featuring Richard Lafayette, MD, FACP, from Stanford University Medical Center, who will join company management…
Join eFFECTOR Therapeutics for a virtual investor R&D day which will feature presentations by eFFECTOR management and Dr. Kevin Kalinsky,…
LifeSci Partners invites you to register for our 13th Annual Corporate Access Event Featuring more than 150 publicly trading and…
Join Oryzon Genomics for a data call to discuss topline results from the Phase IIb PORTICO study evaluating vafidemstat in…
Join us for a virtual R&D Day with Aspira Women’s Health, featuring experts who will present the exciting progress of…

Join Nusano for a virtual KOL panel discussion led by Suji Jeong, PhD (Founding Partner, The SJR Group), featuring Phil Nicklin (Senior Analyst, LifeSci Consulting), Dr.…
Join us for a virtual KOL Event with Mendus, featuring Dr. Arjan van de Loosdrecht, Professor of Hematology at Amsterdam UMC, who…
Join us for a Virtual R&D Day with BioAtla, featuring Omid Hamid, MD (Cedars Sinai: The Angeles Clinic and Research…
Join Shattuck Labs, Inc. for a data call to present the initial data from the frontline expansion cohorts in HR-MDS…
Join the Ligand Pharmaceuticals Annual Investor Day in-person or via webcast, discussing Ligand's strategy, portfolio, and financial outlook supporting the clinical development of…